nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adeno-Associated Virus Serotype 9–Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts With Left Ventricular Dysfunction Secondary to a Myocardial Infarction
|
Knezevic, Tijana |
|
2016 |
1 |
7 |
p. 647-656 10 p. |
artikel |
2 |
A Growth Tonic for Heart Failure? ∗
|
Bishopric, Nanette H. |
|
2016 |
1 |
7 |
p. 587-589 3 p. |
artikel |
3 |
A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure
|
Lenihan, Daniel J. |
|
2016 |
1 |
7 |
p. 576-586 11 p. |
artikel |
4 |
Applying Modern Transcriptomics to Interrogate the Human Cardiac Fibroblast ∗
|
Kanisicak, Onur |
|
2016 |
1 |
7 |
p. 603-605 3 p. |
artikel |
5 |
A Transcriptomic and Epigenomic Comparison of Fetal and Adult Human Cardiac Fibroblasts Reveals Novel Key Transcription Factors in Adult Cardiac Fibroblasts
|
Jonsson, Malin K.B. |
|
2016 |
1 |
7 |
p. 590-602 13 p. |
artikel |
6 |
Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain Reverses Cardiac Dysfunction Caused by Sustained Beta-Adrenergic Receptor Stimulation
|
Gao, Mei Hua |
|
2016 |
1 |
7 |
p. 617-629 13 p. |
artikel |
7 |
Circulating PCSK9 and Risk of Myocardial Infarction
|
Laugsand, Lars E. |
|
2016 |
1 |
7 |
p. 568-575 8 p. |
artikel |
8 |
Editorial Board
|
|
|
2016 |
1 |
7 |
p. i-iii nvt p. |
artikel |
9 |
Fine Tuning Adenylyl Cyclase as a (Gene) Therapy for Heart Failure ∗
|
Port, J. David |
|
2016 |
1 |
7 |
p. 630-632 3 p. |
artikel |
10 |
Genome-Wide Association Studies Candidate Gene to Dual Modifier of Nonalcoholic Steatohepatitis and Atherosclerosis
|
Miller, Clint L. |
|
2016 |
1 |
7 |
p. 680-683 4 p. |
artikel |
11 |
Improving Left Ventricular Myocardial Function After Myocardial Infarction
|
McTiernan, Charles F. |
|
2016 |
1 |
7 |
p. 657-659 3 p. |
artikel |
12 |
Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
|
Saleh, Mohamed A. |
|
2016 |
1 |
7 |
p. 606-616 11 p. |
artikel |
13 |
Innovative Therapeutics
|
Meems, Laura M.G. |
|
2016 |
1 |
7 |
p. 557-567 11 p. |
artikel |
14 |
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
|
Ali, Muhammad |
|
2016 |
1 |
7 |
p. 633-643 11 p. |
artikel |
15 |
The Affordable Care Act’s Hospital Readmissions Reduction Program
|
Mann, Douglas L. |
|
2016 |
1 |
7 |
p. 687-689 3 p. |
artikel |
16 |
The National Heart, Lung, and Blood Institute Small Business Program
|
Marek, Kurt W. |
|
2016 |
1 |
7 |
p. 660-665 6 p. |
artikel |
17 |
The Resurrection of Myeloperoxidase as a Therapeutic Target
|
Taylor, Angela M. |
|
2016 |
1 |
7 |
p. 644-646 3 p. |
artikel |
18 |
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
|
Thomson, Kassandra S. |
|
2016 |
1 |
7 |
p. 666-679 14 p. |
artikel |
19 |
Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
|
Ryan, John J. |
|
2016 |
1 |
7 |
p. 684-686 3 p. |
artikel |